Palatin Technologies, Inc. (PTN) has faced significant share declines, coupled with negative analyst estimates and limited profitability. However, the biotechnology industry as a whole is steadily expanding due to rapid drug development, technological innovations, and robust government support.
In light of these industry dynamics, investors might want to consider investing in more fundamentally sound biotech stocks Protalix BioTherapeutics, Inc. (PLX), Exelixis, Inc. (EXEL) and Jazz Pharmaceuticals plc (JAZZ) for potentially better returns. Let’s understand this in detail.
